SmarterDividends
DGX

Quest Diagnostics Incorporated

DGX

Healthcare · Stock · quarterly payer

$246.45

Overvalued · -24% Add to Portfolio

Forward Yield

1.40%

Annual Dividend

$3.44

Payout Ratio

26%

5-Yr Growth

7.3%

Ex-Date

Oct 6, 2026

Frequency

Quarterly

Summary

As of September 2026, Quest Diagnostics Incorporated (DGX) yields 1.40% ($3.44 per share annually), with a blended fair-value estimate of $187.65 — -24% downside, so it screens as overvalued. Dividend safety grade: A (94/100). 14 years of dividend growth.

Is DGX a good dividend stock?

Yes

Quest Diagnostics Incorporated (DGX) pays a quarterly dividend yielding 1.40% ($3.44/yr), with 14 years of growth and a dividend-safety grade of A. It scores well across payout coverage, growth history and safety — a dependable income holding.

Advantages

  • 14 consecutive years of dividend growth
  • Never cut its dividend on record
  • Comfortable payout ratio (26%)
  • Strong 7.3% 5-yr dividend growth
  • 68% total price return over 5 years
  • Top-tier dividend safety score

Risks

  • Single-stock concentration risk — diversify

Key Data

Dividend Yield
1.40%
Payout Ratio
26%
Annual Dividend
$3.44
5-Yr Avg Growth
7.3%
Ex-Dividend Date
Oct 6, 2026
Years of Growth
14
Frequency
quarterly
Beta
0.55
Market Cap
$27.2B
P/E Ratio
26.2
5-Yr Total Return
68%
52-Week Range
$171.18 – $248.70
Dividend Safety
A · 94/100
Ever Cut?
No
DGX ex-dividend date & scheduleNext ex-date Oct 6, 2026 · full ex-dividend historyView →

Frequently Asked Questions